News
The latest AHA Today headline news stories.
The Sept. 12-13 sessions seek input on whether to permit telemedicine prescribing for certain controlled substances without an in-person evaluation.
Pfizer will ship certain sterile injectable products directly to customers due to high demand after a tornado struck the plant that makes them.
The Centers for Medicare & Medicaid Services April 4 issued a proposed rule for fiscal year 2024 for the skilled nursing facility prospective payment system, which would increase aggregate Medicare spending by 3.7% or $1.2 billion compared with FY 2023.
Beginning Oct. 1, 2022, IRFs have been required to collect and report new data elements adopted into the IRF PAI V4.0.
Today AHA released a report showing that commercial insurance costs are increasing at an unsustainable rate while many plan policies create dangerous delays in care, contribute to clinician burnout and significantly drive up administrative costs for the health care system.
COVID-19 remained the third leading cause of death after heart disease and cancer in 2021, according to preliminary data released Friday by the Centers for Disease Control and Prevention. COVID-19 death rates were highest among people aged 85 and older; Native Hawaiian/Other Pacific Islander…
The Centers for Medicare & Medicaid Services Friday released a proposed rule that would implement provisions in the Consolidated Appropriations Act of 2021 that revise the effective dates of coverage in traditional Medicare; authorize special enrollment periods for certain eligible…
AHA Friday voiced support for a Department of Homeland Security proposal to exclude noncash benefits, such as the Children’s Health Insurance Program and most Medicaid benefits, when making a public charge inadmissibility determination for noncitizens requesting admission to the United States…
The AHA and its American Organization for Nursing Leadership today published an advertorial in the Wall Street Journal on the need for federal legislation to protect nurses and other health care workers from assault and intimidation.
The Food and Drug Administration today expanded its approval for remdesivir (Veklury) to include pediatric patients under age 12 who test positive for SARS-CoV-2 and are hospitalized or at high risk of progressing to severe COVID-19. The patient must be at least 28 days old and weigh at least…